E-LIB Suche - Ergebnisse für: Roe, Matthew T

1

Safety of the PCSK9 inhibitor alirocumab: insights from 47 ..:

Goodman, Shaun G ; Steg, Philippe Gabriel ; Szarek, Michael...
European Heart Journal - Cardiovascular Pharmacotherapy. , 2024

Link: https://doi.org/10.1093/..

2

Age and Aspirin Dosing in Secondary Prevention of Atheroscl..:

Marquis‐Gravel, Guillaume ; Stebbins, Amanda ; Wruck, Lisa M....
Journal of the American Heart Association. 13 (2024) 4 - p. , 2024

Link: https://doi.org/10.1161/..

3

Aspirin Dosing for Secondary Prevention of Atherosclerotic ..:

Girotra, Saket ; Stebbins, Amanda ; Wruck, Lisa...
Journal of the American Heart Association. 12 (2023) 20 - p. , 2023

Link: https://doi.org/10.1161/..

4

Leveraging electronic health records to streamline the cond..:

Khan, Muhammad Shahzeb ; Usman, Muhammad Shariq ; Talha, Khawaja M...
European Heart Journal. 44 (2023) 21 - p. 1890-1909 , 2023

Link: https://doi.org/10.1093/..

5

Outcomes After Acute Coronary Syndrome in Patients With Dia..:

Attar, Rubina ; Wu, Angie ; Wojdyla, Daniel...
The American Journal of Cardiology. 178 (2022) - p. 11-17 , 2022

Link: https://doi.org/10.1016/..

6

Preexisting frailty and outcomes in older patients with acu..:

Udell, Jacob A. ; Lu, Di ; Bagai, Akshay...
American Heart Journal. 249 (2022) - p. 34-44 , 2022

Link: https://doi.org/10.1016/..

7

Cardiovascular Events and Long‐Term Risk of Sudden Death Am..:

Fordyce, Christopher B. ; Giugliano, Robert P. ; Cannon, Christopher P....
Journal of the American Heart Association. 11 (2022) 4 - p. , 2022

Link: https://doi.org/10.1161/..

8

Enabling patient-reported outcome measures in clinical tria..:

Coles, Theresa M. ; Hernandez, Adrian F. ; Reeve, Bryce B....
Health and Quality of Life Outcomes. 19 (2021) 1 - p. , 2021

Link: https://doi.org/10.1186/..

9

Post-COVID-19 Syndrome: Leveraging the Patient Perspective ..:

Roe, Matthew T. ; Patrick-Lake, Bray ; von Eschenbach, Andrew C.
Drugs. 81 (2021) 10 - p. 1235-1237 , 2021

Link: https://doi.org/10.1007/..

10

Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients ..:

Schwartz, Gregory G. ; Szarek, Michael ; Bittner, Vera A....
Journal of the American College of Cardiology. 78 (2021) 5 - p. 421-433 , 2021

Link: https://doi.org/10.1016/..

11

Continued investigator engagement: Reasons principal invest..:

Dombeck, Carrie B. ; Hinkley, Terri ; Fordyce, Christopher B....
Contemporary Clinical Trials Communications. 17 (2020) - p. 100502 , 2020

Link: https://doi.org/10.1016/..

12

Intensity of statin treatment after acute coronary syndrome..:

Diaz, Rafael ; Li, Qian H ; Bhatt, Deepak L...
European Journal of Preventive Cardiology. 28 (2020) 1 - p. 33-43 , 2020

Link: https://doi.org/10.1177/..

13

Elevated Uric Acid Prevalence and Clinical Outcomes in Pati..:

Carnicelli, Anthony P. ; Sun, Jie-Lena ; Alhanti, Brooke...
The American Journal of Medicine. 133 (2020) 12 - p. e716-e721 , 2020

Link: https://doi.org/10.1016/..

14

Drug Development in Kidney Disease: Proceedings From a Mult..:

Edmonston, Daniel L. ; Roe, Matthew T. ; Block, Geoffrey...
American Journal of Kidney Diseases. 76 (2020) 6 - p. 842-850 , 2020

Link: https://doi.org/10.1053/..

15

Effect of Alirocumab on Lipoprotein(a) and Cardiovascular R..:

Bittner, Vera A. ; Szarek, Michael ; Aylward, Philip E....
Journal of the American College of Cardiology. 75 (2020) 2 - p. 133-144 , 2020

Link: https://doi.org/10.1016/..